Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Volitionrx News

    0,9137 $ +2,65% +0,0235 $
    In : 0,8545 € | 26.04.24 22:10:00 AMEX aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A12B6K
    ISIN: US9286611077
    US-Symbol: VNRX
    Typ: Aktie

    Volitionrx News

    23.04.24 - PR Newswire
    Nu.Q® Vet Cancer Test launched in-clinic in U.S. and Europe through Antech
    Nu.Q® Vet Cancer Test launched in-clinic in U.S. and Europe through Antech PR Newswire
    25.03.24 - PR Newswire
    VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business Update
    VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business Update PR Newswire
    21.03.24 - PR Newswire
    VolitionRx Limited Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call and Business Update
    VolitionRx Limited Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call and Business Update PR Newswire
    20.03.24 - PR Newswire
    Volition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer Test in Japan
    Volition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer Test in Japan PR Newswire
    19.03.24 - PR Newswire
    Volition appoints Dr Andrew Retter as Chief Medical Officer
    Volition appoints Dr Andrew Retter as Chief Medical Officer PR Newswire
    02.02.24 - PR Newswire
    Volition to Share Nu.Q® NETs Strategy Update at Upcoming Webinar
    Volition to Share Nu.Q® NETs Strategy Update at Upcoming Webinar PR Newswire
    04.01.24 - PR Newswire
    Volition Issues Business Review 2023
    Volition Issues Business Review 2023 PR Newswire
    05.12.23 - PR Newswire
    VolitionRx Secures Approximately $5.5 Million in Belgium Regional Government Financing from Wallonie Entreprendre
    VolitionRx Secures Approximately $5.5 Million in Belgium Regional Government Financing from Wallonie Entreprendre PR Newswire
    14.11.23 - PR Newswire
    VolitionRx Limited Announces Third Quarter 2023 Financial Results and Business Update
    VolitionRx Limited Announces Third Quarter 2023 Financial Results and Business Update PR Newswire
    08.11.23 - PR Newswire
    VolitionRx Limited Schedules Third Quarter 2023 Earnings Conference Call and Business Update
    VolitionRx Limited Schedules Third Quarter 2023 Earnings Conference Call and Business Update PR Newswire
    06.11.23 - PR Newswire
    Volition and VPG Launch Nu.Q® Vet Cancer Test in UK & Ireland
    Volition and VPG Launch Nu.Q® Vet Cancer Test in UK & Ireland PR Newswire
    06.11.23 - PR Newswire
    Volition and VPG Launch Nu.Q® Vet Cancer Test in UK & Ireland
    Volition and VPG Launch Nu.Q® Vet Cancer Test in UK & Ireland PR Newswire
    23.10.23 - PR Newswire
    Volition Presents Breakthrough Liquid Biopsy Blood Test Method for Early-stage Cancer
    Volition Presents Breakthrough Liquid Biopsy Blood Test Method for Early-​stage Cancer PR Newswire
    19.10.23 - PR Newswire
    Measuring Nucleosomes Using Nu.Q® NETs is a Promising Biomarker for Septic Shock
    Measuring Nucleosomes Using Nu.Q® NETs is a Promising Biomarker for Septic Shock PR Newswire
    18.10.23 - PR Newswire
    US Ambassador Adler visits Belgian Volition
    US Ambassador Adler visits Belgian Volition PR Newswire
    16.10.23 - PR Newswire
    Volition Presents Three Cancer Detection Abstracts at ESMO 2023
    Volition Presents Three Cancer Detection Abstracts at ESMO 2023 PR Newswire
    13.10.23 - PR Newswire
    Volition Publishes Key Opinion Leader Roundtable Report on NETs in Sepsis
    Volition Publishes Key Opinion Leader Roundtable Report on NETs in Sepsis PR Newswire
    02.10.23 - PR Newswire
    Volition to Reveal New Cancer Detection Method Insights at Upcoming Webinar
    Volition to Reveal New Cancer Detection Method Insights at Upcoming Webinar PR Newswire
    13.09.23 - PR Newswire
    Volition Hosts Key Opinion Leader Roundtable on Sepsis Management
    Volition Hosts Key Opinion Leader Roundtable on Sepsis Management PR Newswire
    14.08.23 - PR Newswire
    VolitionRx Limited Announces Second Quarter 2023 Financial Results and Business Update
    VolitionRx Limited Announces Second Quarter 2023 Financial Results and Business Update PR Newswire

    Newssuche

    Videos

    newspaper
    26.04.24 +6,31%
    Technical Trading: Gold Long freitags
    Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »